Eduardo Mysler Selected Research

Eduardo Mysler Research Topics

Disease

36	Rheumatoid Arthritis 03/2024 - 03/2010
9	Infections 03/2024 - 04/2013
8	Herpes Zoster 03/2024 - 11/2019
6	Neoplasms (Cancer) 01/2024 - 11/2019
5	Venous Thromboembolism 03/2024 - 01/2022
4	Psoriatic Arthritis 11/2023 - 12/2020
3	Necrosis 01/2023 - 06/2017
3	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2021 - 06/2018
3	Arthritis (Polyarthritis) 09/2020 - 08/2004
3	Pain (Aches) 11/2019 - 01/2019
2	Ankylosing Spondylitis 11/2023 - 01/2023
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2022
2	Skin Neoplasms (Skin Cancer) 01/2023 - 01/2023
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2023
2	Lupus Nephritis 01/2023 - 05/2009
2	Axial Spondyloarthritis 11/2021 - 12/2020
2	Injection Site Reaction 09/2021 - 12/2020
2	Osteoarthritis 08/2004 - 08/2004
1	Lymphopenia (Lymphocytopenia) 03/2024
1	Pulmonary Embolism 03/2024
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021
1	Drug-Related Side Effects and Adverse Reactions 09/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2020
1	Spondylarthritis (Spinal Arthritis) 09/2020
1	Spondylitis 09/2020
1	Ankylosis 09/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2020
1	Fatigue 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Musculoskeletal Diseases (Musculoskeletal Disease) 05/2016
1	Rheumatic Diseases (Rheumatism) 12/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2013
1	Gouty Arthritis 07/2011
1	Ulcer 08/2004
1	Myocardial Infarction 08/2004

Drug/Important Bio-Agent (IBA)

14	upadacitinibIBA 03/2024 - 11/2019
13	Adalimumab (Humira)FDA Link 03/2024 - 01/2017
12	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 04/2014
9	tofacitinibIBA 03/2024 - 01/2017
8	Biosimilar PharmaceuticalsIBA 09/2021 - 12/2014
6	Janus Kinase InhibitorsIBA 01/2022 - 01/2017
5	Etanercept (Enbrel)FDA Link 09/2021 - 06/2017
4	Creatine Kinase (Creatine Phosphokinase)IBA 03/2024 - 11/2019
4	Tumor Necrosis Factor InhibitorsIBA 03/2024 - 06/2017
4	Abatacept (Orencia)FDA Link 01/2018 - 04/2014
3	Antirheumatic Agents (DMARD)IBA 10/2020 - 06/2017
3	Monoclonal AntibodiesIBA 06/2017 - 07/2011
2	omega-Chloroacetophenone (Mace)IBA 11/2023 - 01/2023
2	baricitinibIBA 04/2023 - 06/2017
2	InterferonsIBA 01/2023 - 04/2013
2	Janus KinasesIBA 01/2022 - 06/2017
2	ixekizumabIBA 11/2021 - 12/2020
2	tocilizumab (atlizumab)FDA Link 10/2020 - 06/2017
2	clazakizumabIBA 06/2017 - 10/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2004 - 08/2004
2	lumiracoxib (prexige)IBA 08/2004 - 08/2004
2	Ibuprofen (Motrin)FDA LinkGeneric 08/2004 - 08/2004
2	Naproxen (Naprosyn)FDA LinkGeneric 08/2004 - 08/2004
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2004 - 08/2004
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2004 - 08/2004
1	anifrolumabIBA 01/2023
1	C-Reactive ProteinIBA 09/2020
1	amsonic acid (DAS)IBA 09/2020
1	GlucocorticoidsIBA 06/2017
1	golimumab FDA Link 06/2017
1	Infliximab (Remicade)FDA Link 06/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 06/2017
1	Rituximab (Mabthera)FDA Link 06/2017
1	sarilumabIBA 06/2017
1	Certolizumab Pegol FDA Link 06/2017
1	sirukumabIBA 06/2017
1	Leflunomide (Arava)FDA LinkGeneric 06/2017
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2017
1	mavrilimumabIBA 06/2017
1	CT-P13IBA 12/2014
1	AntibodiesIBA 08/2014
1	sifalimumabIBA 04/2013
1	Allopurinol (Remid)FDA LinkGeneric 07/2011
1	Uric Acid (Urate)IBA 07/2011
1	Colchicine FDA LinkGeneric 07/2011
1	canakinumab FDA Link 07/2011
1	InterleukinsIBA 07/2011
1	Tuberculin (PPD)IBA 03/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2009
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2009

Therapy/Procedure

9	Therapeutics 03/2024 - 05/2009
1	Biological Therapy 08/2014